Check out the companies making headlines before the bell. Procter & Gamble — The stock fell 0.8% after reporting weaker-than-expected revenue. The household goods maker posted $21.74 billion in revenue while analysts polled by LSEG had estimated $21.91 billion. The company attributed the miss to lower demand in China. Adjusted earnings per share of $1.93 topped estimates of $1.90 per share. Netflix — Shares popped 6.3% after the streaming giant exceeded Wall Street’s third-quarter expectations. Netflix reported earnings per share of $5.40 on revenue of $9.83 billion, while analysts polled by LSEG forecast earnings of $5.12 a share on revenue of m $9.77 billion. The company also saw its ad-supported membership tier jump 34% quarter-over-quarter. CVS Health – Shares tumbled 11% after the drug store chain announced longtime executive David Joyner has replaced Karen Lynch as CEO. CVS also guided for third-quarter adjusted earnings between $1.05 and $1.10 per share, less than the $1.69 a share expected from analysts polled by Fact Set. WD-40 — The maintenance product maker’s shares fell 4% after a disappointing fiscal fourth-quarter earnings report. The company reported $1.23 earnings per share, versus FactSet consensus forecasts of earnings of $1.34 per share. Full-year earnings guidance between $5.20 and $5.45 per share also came in short of estimates for $5.69 per share. Western Alliance Bancorp — The regional bank stock dropped more than 4%. Despite posting a top-line beat of $823 million in revenue versus LSEG analysts’ estimates for $808 million, net interest income fell 3% in the third-quarter. American Express — Shares of the credit card company ticked down 3.4% on a mixed earnings report. Revenue of $16.64 billion fell short of the LSEG consensus forecast for $16.67 billion. However, earnings of $3.49 per share topped forecasts of $3.28. Apple — The tech giant advanced 2% after Bloomberg reported that iPhone sales in China jumped 20% year-over-year in the first three weeks of sales. Coherent — The semiconductor materials stock tumbled more than 5% after B.Riley downgraded shares to neutral from buy, citing limited upside potential after shares soared 142% in 2024. SLB — Shares dipped 1.7% after Schlumberger posted third-quarter revenue that fell short of estimates. Revenue of $9.16 billion fell below the $9.25 billion LSEG consensus forecast. On the other hand, adjusted earnings of 89 cents per share topped the 88 cents earnings per share expectation. Intuitive Surgical — The stock added more than 6% after the maker of the da Vinci surgical robot beat on both top and bottom lines in the third quarter. Intuitive Surgical earned $1.84 per share on $2.04 billion in revenue, while analysts surveyed by LSEG had predicted earnings of $1.63 per share on $2 billion in revenue. Ally Financial – The digital bank stock fell nearly 1% despite earnings beating analysts’ estimates in the third quarter. The company announced adjusted earnings per share of 95 cents on $2.1 billion in revenue. Analysts surveyed by FactSet had called for 52 cents earnings per share and revenue of $2.03 billion. Crown Holdings — The consumer goods packaging company ticked up more than 4% after raising its full-year guidance. Crown Holdings is guiding toward adjusted earnings per share falling between $6.25 and $6.35 per share. Analysts had expected $6.15 earnings per share, per FactSet. Adjusted earnings topped estimates in the third quarter, while revenue came in line with forecasts. Comerica — Shares of the mid-sized bank ticked up nearly 1% after a stronger-than-expected report for the third quarter. Comerica generated $1.33 in earnings per share on $534 million of revenue, compared to $1.17 per share and $527.9 million of revenue expected by analysts, according to FactSet. Net income for the bank was down year over year. — CNBC’s Pia Singh, Sarah Min, Jesse Pound, Michelle Fox contributed reporting
Bitcoin fell below the $79,000 level as investors braced for more financial market volatility after U.S. equites suffered their worst decline since 2020 on the rollout of President Donald Trump’s restrictive global tariffs.
The price of bitcoin was last lower by 4% at $78,835.07, according to Coin Metrics, after trading above the $80,000 for most of this year — barring a couple brief blips below it amid recent volatility. It’s off its January all-time high by about 34%.
Although the flagship cryptocurrency usually trades like a big tech stock and is often viewed by traders as a leading indicator of market sentiment, it bucked the broader market meltdown last week – holding in the $80,000 to $90,000 range and rising to end the week as stocks tumbled and even gold fell.
Other cryptocurrencies suffered bigger losses overnight. Ether and the token tied to Solana tumbled 9% each.
Bitcoin’s down move triggered a wave of long liquidations, as traders betting on an increase in its price were forced to sell their assets to cover their losses. In the past 24 hours, bitcoin has seen more than $181 million in long liquidations, according to CoinGlass. Ether saw $188 million in long liquidations in the same period.
Bitcoin has traded mostly above $80,000 in 2025
Rattled investors dumped their holdings of cryptocurrencies, which trade 24 hours, over the weekend as they anticipated further carnage, after Trump’s retaliatory tariffs raised global recession fears and caused investors to sell all risk.
The duties on all imports, in addition to custom tariffs for major trading partners, have sparked worries of a global trade war that could lead the U.S. into a recession. Growing concerns about the far-reaching impact of the tariffs sent markets reeling worldwide.
In the two sessions following the tariff announcement, global stocks wiped out $7.46 trillion in market value based on the market cap of the S&P Global Broad Market Index, according to S&P Dow Jones Indices.
That figure includes $5.87 trillion lost in the U.S. stock market over those two sessions and another $1.59 trillion loss in market value in other major global markets.
Bitcoin is down 15% in 2025 and, absent a crypto-specific catalyst, is expected to continue moving in tandem with equities as global recession fears overshadow any regulatory tailwinds crypto was expected to benefit from this year.
Worries about tariffs may have rattled global investors, but analysts still expect China’s technology sector to keep riding this year’s wave of interest in homegrown generative artificial intelligence. The latest salvo of U.S. tariffs on China and its Southeast Asia trading partners sent Chinese stocks tumbling at the open Thursday, but they closed well off their lows. Local markets were closed Friday for a holiday. “Many of the larger tech names (and most of the consumer names) have limited exposure to the U.S. market despite some overreaction at first,” Kai Wang, Asia equity strategist at Morningstar, said in a statement Thursday. “We are expecting some fiscal policy intervention,” he said, “should there be incremental macro weakness.” China’s finance ministry indicated last month it was holding onto some dry powder given domestic and overseas uncertainties. Chinese policymakers are expected to hold a regular meeting later this month. Chinese tech stock valuations still look inexpensive relative to those in the U.S., Citi China equity strategist Pierre Lau and a team said in a report Thursday. They pointed out that average price-to-earnings ratio of seven leading tech-related Chinese stocks is 52% below that of U.S “Magnificent Seven” — not yet recovered to the historical average of 33% in the past five years. “We prefer domestic over export plays amid uncertainties stemming from higher tariffs,” the Citi strategists said. They also prefer services over goods sectors, and also like growth more than value. The firm is overweight on China internet, technology and transportation stock sectors. Citi’s top China stock buys include social media and gaming company Tencent , electric car giant BYD and home appliance company Haier , all listed in Hong Kong. Growing investor interest In a sign of how much investor interest has grown, nearly one-quarter of international investors have turned more positive on Chinese tech, the Citi strategists said, citing the firm’s U.S. marketing work last month. Global emerging markets equity funds’ allocation to China hit a 16-month high in late March , according to EPFR. Chinese startup DeepSeek released an AI model in late January that claimed to outperform OpenAI’s ChatGPT, despite U.S. restrictions on Chinese access to advanced chips for AI training. AI adoption is also expected to help Chinese companies cut costs , while policy aims to support consumer growth. Initial upgrades to Chinese companies’ earnings expectations are being driven by high-tech sectors and selected consumer companies, HSBC analysts pointed out Thursday. An index of 10 major Chinese tech companies traded in Hong Kong closed 1.2% lower Thursday, slightly better than the overall Hang Seng index’s 1.5% drop. The tech index remains more than 20% higher year to date, versus gains of just under 14% for the Hang Seng index. Another sector investment analysts say is relatively sheltered from the new tariffs is Chinese health care as pharmaceuticals were excluded from Trump’s latest round of tariffs. “Even if Trump imposed any tariffs in the future, most Chinese biotechs have U.S. partners and are not considered exporters, and tariffs on bulk drug makers could easily be transferred to downstream U.S. pharma,” Jefferies equity analyst Cui Cui and a team said in a note Wednesday. They also don’t expect reviving targeted legislation, such as the expired Biosecure Act , to become a U.S. priority soon. The Biosecure Act sought to restrict Chinese drug companies such as Wuxi Biologics from federal contracts. “Given that lowering drug prices in the U.S. is supported by both Republicans and Democrats, giving U.S. pharma companies the flexibility to operate efficiently and maintain an optimal cost structure is essential,” the Jefferies analysts said, highlighting expectations that Wuxi Biologics can operate at least twice as efficiently than competitors Samsung Bio and Lonza. Hong Kong-listed Wuxi Biologics said in late March that it expected ” accelerated and profitable growth in 2025 .” Jefferies rates the stock a buy. However, the extent of new U.S. tariffs and impact on China’s economy remains unclear. Morningstar’s Wang cautioned that tariffs would indirectly affect the tech sector given the likely negative impact on China’s gross domestic product, while market volatility may increase.
Warren Buffett went on the record Friday to deny social media posts after President Donald Trump shared on Truth Social a fan video that claimed the president is tanking the stock market on purpose with the endorsement of the legendary investor.
Trump on Friday shared an outlandish social media video that defends his recent policy decisions by arguing he is deliberately taking down the market as a strategic play to force lower interest and mortgage rates.
“Trump is crashing the stock market by 20% this month, but he’s doing it on purpose,” alleged the video, which Trump posted on his Truth Social account.
The video’s narrator then falsely states, “And this is why Warren Buffett just said, ‘Trump is making the best economic moves he’s seen in over 50 years.'”
The president shared a link to an X post from the account @AmericaPapaBear, a self-described “Trumper to the end.” The X post itself appears to be a repost of a weeks-old TikTok video from user @wnnsa11. The video has been shared more than 2,000 times on Truth Social and nearly 10,000 times on X.
Buffett, 94, didn’t single out any specific posts, but his conglomerate Berkshire Hathaway outright rejected all comments claimed to be made by him.
“There are reports currently circulating on social media (including Twitter, Facebook and Tik Tok) regarding comments allegedly made by Warren E. Buffett. All such reports are false,” the company said in a statement Friday.
CNBC’s Becky Quick spoke to Buffett Friday about this statement and he said he wanted to knock down misinformation in an age where false rumors can be blasted around instantaneously. Buffett told Quick that he won’t make any commentary related to the markets, the economy or tariffs between now and Berkshire’s annual meeting on May 3.
‘A tax on goods’
While Buffett hasn’t spoken about this week’s imposition of sweeping tariffs from the Trump administration, his view on such things has pretty much always been negative. Just in March, the Berkshire CEO and chairman called tariffs “an act of war, to some degree.”
“Over time, they are a tax on goods. I mean, the tooth fairy doesn’t pay ’em!” Buffett said in the news interview with a laugh. “And then what? You always have to ask that question in economics. You always say, ‘And then what?'”
During Trump’s first term, Buffett opined at length in 2018 and 2019 about the trade conflicts that erupted, warning that the Republican’s aggressive moves could cause negative consequences globally.
“If we actually have a trade war, it will be bad for the whole world … everything intersects in the world,” Buffett said in a CNBC interview in 2019. “A world that adjusts to something very close to free trade … more people will live better than in a world with significant tariffs and shifting tariffs over time.”
Buffett has been in a defensive mode over the past year as he rapidly dumped stocks and raised a record amount of cash exceeding $300 billion. His conglomerate has a big U.S. focus and has large businesses in insurance, railroads, manufacturing, energy and retail.